HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes Siegrist Selected Research

Occupational Stress

12/2021Effort-Reward Imbalance at Work and Drug Misuse: Evidence from a National Survey in the U.S.
11/2019Effort-reward imbalance at work is associated with hair cortisol concentrations: Prospective evidence from the Dresden Burnout Study.
1/2018Associations of work stress with hair cortisol concentrations - initial findings from a prospective study.
11/2017Work Stress and Altered Biomarkers: A Synthesis of Findings Based on the Effort-Reward Imbalance Model.
2/2011Stress management interventions in the workplace improve stress reactivity: a randomised controlled trial.
5/2010Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
1/2008Higher overcommitment to work is associated with lower norepinephrine secretion before and after acute psychosocial stress in men.
6/2005A prospective study of cumulative job stress in relation to mental health.
5/2004Effort-reward imbalance, overcommitment, and measures of cortisol and blood pressure over the working day.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johannes Siegrist Research Topics

Disease

9Occupational Stress
12/2021 - 05/2004
4Inflammation (Inflammations)
11/2017 - 09/2006
4Coronary Artery Disease (Coronary Atherosclerosis)
03/2011 - 08/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 08/2002
2Obesity
01/2018 - 01/2013
2Hypertension (High Blood Pressure)
01/2018 - 01/2006
2Coronary Disease (Coronary Heart Disease)
11/2017 - 01/2013
2Atherosclerosis
04/2008 - 09/2007
2Myocardial Infarction
01/2006 - 08/2002
1Drug Misuse
12/2021
1Opioid-Related Disorders (Opiate Addiction)
12/2021
1Chronic Disease (Chronic Diseases)
01/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2017
1Prediabetic State (Prediabetes)
12/2013
1Mobility Limitation (Difficulty Walking)
01/2013
1Heart Diseases (Heart Disease)
01/2013
1Cognitive Dysfunction
01/2012
1Mental Disorders (Mental Disorder)
08/2007
1Fatigue
06/2005
1Lipodystrophy
09/2002
1Death (Near-Death Experience)
08/2002
1Musculoskeletal Pain
01/2002

Drug/Important Bio-Agent (IBA)

5Hydrocortisone (Cortisol)FDA LinkGeneric
11/2019 - 05/2004
4Biological ProductsIBA
11/2017 - 01/2006
3LipidsIBA
11/2017 - 01/2006
3C-Reactive ProteinIBA
01/2012 - 04/2008
2CalciumIBA
09/2007 - 08/2002
1Hypnotics and Sedatives (Sedatives)IBA
12/2021
1CholesterolIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
11/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2013
1Glucose (Dextrose)FDA LinkGeneric
12/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2011
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2010
1Petroleum (Crude Oil)IBA
08/2007
1TroponinIBA
09/2006
1Psychotropic Drugs (Psychoactive Drugs)IBA
06/2005

Therapy/Procedure

1Vocational Rehabilitation
01/2020
1Activities of Daily Living (ADL)
01/2013
1Therapeutics
03/2011
1Highly Active Antiretroviral Therapy (HAART)
09/2002
1Secondary Prevention
01/2002